Menu Back toSession 12: Co-track Grand Q&A Panel and Closing Remarks

DIA/FDA Oligonucleotide-Based Therapeutics Conference

DIA Your Way! Join us live in-person or live from the comfort of your home/office. This event offers two learning avenues depending on your preference!

Session 12: Co-track Grand Q&A Panel and Closing Remarks

Session Chair(s)

Ramesh Raghavachari, PhD

Ramesh Raghavachari, PhD

  • Chief, Branch I, DPMA1, OLDP, OPQ, CDER
  • FDA, United States
Session 12: Co-track Grand Q&A Panel and Closing Remarks

Speaker(s)

Nedim Emil Altaras, PhD

Speaker

Nedim Emil Altaras, PhD

  • Senior Vice President, Technical Development
  • Moderna, United States
Paul C. Brown, PhD

Panelists

Paul C. Brown, PhD

  • ODE Associate Director for Pharmacology and Toxicology, OND, CDER
  • FDA, United States
Daniel Capaldi Capaldi, PhD

Speaker

Daniel Capaldi Capaldi, PhD

  • Vice President, Analytical and Process Development
  • Ionis Pharmaceuticals, Inc, United States
Jeffrey Foy, PhD

Speaker

Jeffrey Foy, PhD

  • Vice President, Toxicology
  • PepGen Inc., United States
Lois M. Freed, PhD

Panelist

Lois M. Freed, PhD

  • Director, Division of Pharmacology/Toxicology-Neuroscience (DPT-N), CDER
  • FDA, United States
Laura Sepp-Lorenzino, PhD

Speaker

Laura Sepp-Lorenzino, PhD

  • Chief Scientific Officer
  • Intellia Therapeutics, Inc., United States
Barry Ticho, MD, PhD

Panelist

Barry Ticho, MD, PhD

  • Chief Medical Officer
  • Stoke Therapeutics, United States

Contact us

Registration Questions?

Send Email
1.888.257.6457

Additional Information

Live Meeting Policies

Discover DIA’s Live In-Person and Live Virtual Events